A legal marijuana company has placed an offer on the K2 building, and the offer has been accepted, according to Dan Anglin, a spokesman for the company, Bakkhos Holding.
Anglin said on Tuesday that Bakkhos Holding — a company with Seattle-area investors — is now under contract to purchase the building from K2, which is owned by the Jarden Corporation, but the purchase has not been completed. The company is currently performing inspections at the property, and Anglin was unsure when the sale might close.
Last month Bakkhos Holding applied with the state to both grow and process marijuana at the 180,000-square-foot K2 building. Should the sale go through and should Bakkhos be granted a state license as well as King County permits, the company would grow marijuana and manufacture Edipure-brand edible marijuana products at the building. The products would be sold to off-island distributors.
The owners of Bakkhos Holding have been involved in the medical marijuana market since 2012, distributing Edipure products through their nonprofit, Green Cross Washington.
Anglin said that while the building's sale is not yet official and a long permitting process is also ahead, the company has done thorough research and is optimistic that it will be able to set up its operation at the K2 location.
Anglin added that company is excited about the prospect of locating the new business on Vashon and representatives hope to be in close contact community members once they take ownership of the building and move forward with their plans.
"We're confident this building meets our needs, is zoned appropriately, and now our focus is ... on the community," he said.
Representatives of Cushman & Wakefield, the commercial real estate broker selling the building, did not return phone calls from The Beachcomber on Tuesday.
Watch The Beachcomber for more information.